OR WAIT null SECS
© 2022 MJH Life Sciences and Diagnostic Imaging. All rights reserved.
© 2022 MJH Life Sciences™ and Diagnostic Imaging. All rights reserved.
December 01, 2021
PSMA PET is highly robust in identifying prostate cancer lesions which are otherwise deemed unremarkable.
An artificial intelligence for digital breast tomosynthesis enhances radiologists’ performance and efficiency.
November 30, 2021
Following breast cancer treatment, women who have access to breast MRI may safely forgo additional mammographic or digital breast tomosynthesis follow-up.
A deep learning model was developed to detect intracranial hemorrhage in computed tomography scans without medical annotation.
Multiparametric MRI can detect pathologic complete response after neoadjuvant therapy in patients with esophageal squamous cell carcinoma.
Sonographic quantitative assessment of the deltoid muscle could translate into a dedicated, simple and noninvasive screening method to detect type 2 diabetes.
November 29, 2021
Findings suggest that patients with suspected axial spondyloarthropathy not taking NSAIDs were more likely to have MRI proven inflammation compared with patients taking NSAIDs.
Breast ultrasound/MRI fusion significantly improves localization of incidentally detected MRI lesions which are occult on an initial ultrasound survey alone.
COVID-19 can result in cardiac complications including myocarditis, arterial and venous thromboembolism, and cardiomyopathy.
November 23, 2021
Learn more about what Canon Medical will be showcasing virtually at RSNA 2021.